These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 32234136)

  • 1. [Effectiveness of ketamine in the treatment of refractory and super-refractory status epilepticus in children].
    Wu J; Wang Q; Qian SY; Gao HM; Liu J; Deng J; Zeng JS
    Zhonghua Er Ke Za Zhi; 2020 Apr; 58(4):295-300. PubMed ID: 32234136
    [No Abstract]   [Full Text] [Related]  

  • 2. (S)-Ketamine in Refractory and Super-Refractory Status Epilepticus: A Retrospective Study.
    Höfler J; Rohracher A; Kalss G; Zimmermann G; Dobesberger J; Pilz G; Leitinger M; Kuchukhidze G; Butz K; Taylor A; Novak H; Trinka E
    CNS Drugs; 2016 Sep; 30(9):869-76. PubMed ID: 27465262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine in the treatment of refractory and super-refractory status epilepticus: Experience from two centres.
    García-Ruiz M; Rodríguez PM; Palliotti L; Lastras C; Romeral-Jiménez M; Morales IG; Rey CP; Rodrigo-Gisbert M; Campos-Fernández D; Santamarina E; Carbonell BP
    Seizure; 2024 Apr; 117():13-19. PubMed ID: 38301485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vagus nerve stimulation in refractory and super-refractory status epilepticus - A systematic review.
    Dibué-Adjei M; Brigo F; Yamamoto T; Vonck K; Trinka E
    Brain Stimul; 2019; 12(5):1101-1110. PubMed ID: 31126871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of mortality and long-term outcome in children with refractory and super refractory status epilepticus.
    Jayalakshmi S; Patil A; Challa A; Parekh M; Khandelia H; Vooturi S
    J Clin Neurosci; 2022 Mar; 97():12-16. PubMed ID: 35030458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of perampanel oral suspension for the treatment of refractory and super-refractory status epilepticus.
    Bruschi G; Pellegrino L; Bisogno AL; Ferreri F; Kassabian B; Seppi D; Favaretto S; Corbetta M; Dainese F
    Epilepsy Behav; 2024 Jul; 156():109826. PubMed ID: 38761446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific characteristics and current diagnostic and treatment modalities performance of super refractory status epilepticus in children: A comparative study.
    Briassoulis G; Stefanogianni C; Zaganas I; Raissaki M; Briassoulis P; Ilia S
    Eur J Paediatr Neurol; 2022 Mar; 37():32-39. PubMed ID: 35051734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic hypothermia for pediatric refractory status epilepticus May Ameliorate post-status epilepticus epilepsy.
    Hsu MH; Kuo HC; Lin JJ; Chou MY; Lin YJ; Hung PL
    Biomed J; 2020 Jun; 43(3):277-284. PubMed ID: 32330677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric refractory and super-refractory status epilepticus.
    Vasquez A; Farias-Moeller R; Tatum W
    Seizure; 2019 May; 68():62-71. PubMed ID: 29941225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine for the treatment of refractory status epilepticus.
    Fang Y; Wang X
    Seizure; 2015 Aug; 30():14-20. PubMed ID: 26216679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine reduces seizure and interictal continuum activity in refractory status epilepticus: a multicenter in-person and teleneurocritical care study.
    Harnicher B; Murray NM; Dresbach J; Collingridge DS; Reachi B; Bair J; Hoang Q; Fontaine GV
    Neurol Sci; 2024 Nov; 45(11):5449-5456. PubMed ID: 38862653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study.
    Delaj L; Novy J; Ryvlin P; Marchi NA; Rossetti AO
    Acta Neurol Scand; 2017 Jan; 135(1):92-99. PubMed ID: 27080243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Super-refractory status epilepticus in West China.
    Tian L; Li Y; Xue X; Wu M; Liu F; Hao X; Zhou D
    Acta Neurol Scand; 2015 Jul; 132(1):1-6. PubMed ID: 25314275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mega-dose phenobarbital therapy for super-refractory status epilepticus.
    Byun JI; Chu K; Sunwoo JS; Moon J; Kim TJ; Lim JA; Jun JS; Lee HS; Lee WJ; Lee DY; Jeon D; Lee ST; Jung KH; Jung KY; Lee SK
    Epileptic Disord; 2015 Dec; 17(4):444-52. PubMed ID: 26575689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with occurrence and outcome of super-refractory status epilepticus.
    Madžar D; Knappe RU; Reindl C; Giede-Jeppe A; Sprügel MI; Beuscher V; Gollwitzer S; Hamer HM; Huttner HB
    Seizure; 2017 Nov; 52():53-59. PubMed ID: 28963934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine to treat super-refractory status epilepticus.
    Alkhachroum A; Der-Nigoghossian CA; Mathews E; Massad N; Letchinger R; Doyle K; Chiu WT; Kromm J; Rubinos C; Velazquez A; Roh D; Agarwal S; Park S; Connolly ES; Claassen J
    Neurology; 2020 Oct; 95(16):e2286-e2294. PubMed ID: 32873691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants and predictors of outcome in super refractory status epilepticus--a developing country perspective.
    Jayalakshmi S; Ruikar D; Vooturi S; Alladi S; Sahu S; Kaul S; Mohandas S
    Epilepsy Res; 2014 Nov; 108(9):1609-17. PubMed ID: 25246354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoflurane treatment for refractory and super-refractory status epilepticus in dogs.
    Sarpekidou E; Polyzois G; Papageorgiou V; Savvas I; Polizopoulou Z; Kazakos G
    Front Vet Sci; 2024; 11():1338894. PubMed ID: 38523714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoflurane in (Super-) Refractory Status Epilepticus: A Multicenter Evaluation.
    Stetefeld HR; Schaal A; Scheibe F; Nichtweiß J; Lehmann F; Müller M; Gerner ST; Huttner HB; Luger S; Fuhrer H; Bösel J; Schönenberger S; Dimitriadis K; Neumann B; Fuchs K; Fink GR; Malter MP;
    Neurocrit Care; 2021 Dec; 35(3):631-639. PubMed ID: 34286464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.